Reparixin, a CXCR1/2 inhibitor in islet allotransplantation

Quality of life in Type 1 diabetic patients may be improved with islet transplantation, but lifelong immunosuppression is required to prevent rejection. Allo-immune response is a key player in graft dysfunction and although the adaptive immune response is well characterized, the effect of the innate...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Islets
Hlavní autoři: Pawlick, Rena L., Wink, John, Pepper, Andrew R., Bruni, Antonio, Abualhassen, Nasser, Rafiei, Yasmin, Gala-Lopez, Boris, Bral, Mariusz, Shapiro, A.M. James
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2016
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029202/
https://ncbi.nlm.nih.gov/pubmed/27328412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19382014.2016.1199303
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky